Every active-duty and reserve service member age 30 or older will now get a mandatory testosterone test every year, under a new Pentagon order signed this summer.
Story Snapshot
- Defense Secretary Pete Hegseth announced the policy, folding testosterone screening into the annual Periodic Health Assessment for troops 30 and up.
- The order came through a formal Pentagon memo dated July 15, titled “Health and Human Performance Optimization to Enhance Military Readiness.”
- Troops under 30 can request the test but are not required to take it, and treatment stays voluntary even after a diagnosis.
- Several doctors and major medical groups say there is no solid evidence broad screening improves combat readiness, and warn it could cause needless treatment.
What the Pentagon Actually Ordered
The policy is spelled out in a signed memorandum, not just a press statement. It requires every active duty and reserve member age 30 and older to be screened for testosterone deficiency as part of their routine health exam.
Pentagon spokesman Sean Parnell confirmed the mandatory age threshold publicly, tying the move to a broader push on troop health and performance.
The US Pentagon issued detailed guidance for a new, mandatory testosterone deficiency screening policy for active-duty and reserve service members age 30 and older, a follow-up to Defense Secretary Pete Hegseth's July announcement https://t.co/uJh0d2pFAQ
— Reuters (@Reuters) September 3, 2026
Hegseth framed the initiative as a readiness issue, not a bodybuilding program. He said the goal is making sure troops “operate at your absolute best,” and stressed the effort is “not about artificial enhancement.”
Service members who test low can choose hormone replacement therapy, but nothing forces them into treatment once a deficiency shows up on paper.
Why Doctors Are Pushing Back Hard
Reuters spoke with six doctors about the plan. Four said there is no solid evidence that screening every man over 30 would actually make the force more combat ready. Five said the announcement left them puzzled and worried it could lead to treatment nobody actually needs.
Urologist Dr. Kevin McVary told Reuters that real-world evidence for testosterone therapy comes from patients who already had symptoms, not from testing healthy people at random.
That distinction matters because major medical groups already have a clear position. The Endocrine Society and the American Urological Association recommend testosterone treatment only for men with confirmed low levels and matching symptoms, things like fatigue, low libido, or lost muscle mass, not for anyone who happens to be over 30.
CBS News reported doctors saying routine screening has never been shown to sharpen thinking or turn a healthy 30-year-old into a better soldier.
False Positives and the Cost Question
Testosterone levels naturally swing with age, sleep, and even the time of day a blood draw happens. Doctors quoted by CBS News warned that testing everyone over 30 risks a high rate of false positives, which then triggers more testing and possibly unnecessary hormone treatment.
Physician Celine Gounder added there is no published cost analysis showing this is smart spending, an odd gap for an administration that talks often about cutting waste.
Fertility and Fairness Concerns Raised on Air
On CNN, Dr. Jonathan Riner explained that many men with low testosterone show no symptoms at all, which is exactly why medical guidelines advise against blanket screening in healthy populations.
He also flagged a practical snag: accurate testing needs a fasting, morning blood draw, and any low result requires a second confirming test before anyone acts on it.
Riner also raised a fairness question worth taking seriously. If testosterone numbers ever start factoring into promotions, deployments, or special assignments, troops could feel pressured to chase treatment they don’t medically need just to protect their career.
He additionally noted therapy itself carries real trade-offs, including lower sperm counts and prostate enlargement, risks that matter for men still building families.
Where This Leaves Troops and Taxpayers
Supporters see a straightforward readiness fix: find a treatable deficiency early and keep the force sharper. Critics, including specialists at the Endocrine Society, say there simply isn’t enough evidence to justify testing every man over 30 who has no symptoms.
Jeremy Samuel Goldman put it bluntly to U.S. Medicine: handing out testosterone broadly “is not going to optimize troops but could cause severe harm”.
The screening itself is mandatory, but treatment remains a choice, which softens some of the coercion worries for now.
Still, taxpayers deserve a clear accounting of what this program costs and whether it delivers measurable readiness gains, not just a confident announcement. Until that data shows up, the debate between Pentagon leadership and the doctors it’s supposed to serve looks far from settled.
Sources:
cbsnews.com, abc11.com, reddit.com, pbs.org, nbcnews.com, urologytimes.com, politico.com
